PMID: 11902527Mar 21, 2002Paper

Prediction of the response of colorectal cancer to systemic therapy

The Lancet Oncology
Julian W AdlardPhil Quirke

Abstract

Adjuvant chemotherapy with fluorouracil and folinic acid improves overall survival for resected carcinoma of the colon of Dukes' stage C by 10-12%. In metastatic disease, response rates with fluorouracil-based regimens are about 25%. Combination with newer agents such as irinotecan and oxaliplatin can improve response rates to more than 50% in selected patients. New treatments with novel molecular targets will soon be entering clinical use. Despite these improvements, many patients undergo chemotherapy for resistant cancer, thus incurring side-effects without benefit. Expression of particular genes can be tested at the protein or RNA level and can be correlated with response or resistance to particular systemic therapies. Thus, predictive-factor testing of tumour biopsy samples may allow us to select chemotherapy or immunotherapy treatments with a high likelihood of benefit for the individual patient.

References

Apr 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M C BrettG Poston
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Feb 1, 1997·World Journal of Surgery·H PereiraF Perpétua
May 20, 1998·Journal of the National Cancer Institute·H J AndreyevP A Clarke
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Jan 13, 2000·The New England Journal of Medicine·R GryfeS Gallinger
Mar 14, 2000·Critical Reviews in Oncology/hematology·B T HillA Kruczynski
Jul 15, 2000·Journal of Biomedical Science·O G ScharovskyP Matar
Sep 28, 2000·The New England Journal of Medicine·L B SaltzL L Miller
Sep 29, 2000·International Journal of Cancer. Journal International Du Cancer·U ManneW E Grizzle
Oct 25, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R SoongB Iacopetta
Mar 20, 2001·Current Oncology Reports·R J Pelley
Sep 15, 2001·BMJ : British Medical Journal·T J Aitman
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·H Vainio
May 23, 2002·International Journal of Colorectal Disease·David J ParkHeinz-Josef Lenz

❮ Previous
Next ❯

Citations

Sep 5, 2006·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Wataru Ichikawa
Jun 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Toshiaki WatanabeTetsuichiro Muto
Apr 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·André B P van Kuilenburg
May 27, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Fariña-SarasquetaA J C van den Brule
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maguy Del RioMarc Ychou
Jun 1, 2011·Radiology and Oncology·Matej Horvat, Borut Stabuc
Feb 22, 2005·Neoplasia : an International Journal for Oncology Research·Martin BuessChristoph Rochlitz
Dec 21, 2010·Chemico-biological Interactions·Guoying NiJiezhong Chen
Dec 14, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sylvie M GuichardDuncan I Jodrell
Feb 20, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Evgeny N Imyanitov, Vladimir M Moiseyenko
May 3, 2008·Journal of Clinical Pharmacy and Therapeutics·Y-F HeW-Q Jiang
Jan 11, 2005·Lancet·Jürgen WeitzMarkus W Büchler
Jun 10, 2006·Cancer Treatment Reviews·Rossana BerardiCascinu Stefano
Aug 10, 2004·International Journal of Cancer. Journal International Du Cancer·Eva FernebroMef Nilbert
Jan 10, 2017·International Journal of Molecular Sciences·Angelika CopijaEwa Nowakowska-Zajdel
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B Michael GhadimiThomas Ried
Sep 15, 2004·Critical Reviews in Oncology/hematology·Bruno VincenziGiuseppe Tonini
Nov 8, 2002·British Medical Bulletin·N J Maughan, P Quirke
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Wolfgang DietmaierFerdinand Hofstädter
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Tomotaka TanakaMasahiko Nishiyama
Jun 7, 2019·Cancer Cell International·Yeying LiuYingjie Zhang
Feb 13, 2018·World Journal of Gastroenterology : WJG·A-Jian LiLu Yin
May 2, 2003·Annals of the New York Academy of Sciences·Adrian M JubbAdam J Oates

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.